Penserra Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-537
| Closed | -$66K | – | 1119 |
|
|
2024
Q4 | $66K | Hold |
537
| – | – | ﹤0.01% | 906 |
|
|
2024
Q3 | $59K | Sell |
537
-36
| -6% | -$3.94K | ﹤0.01% | 838 |
|
|
2024
Q2 | $61K | Buy |
573
+20
| +4% | +$2.2K | ﹤0.01% | 865 |
|
|
2024
Q1 | $66K | Hold |
553
| – | – | ﹤0.01% | 853 |
|
|
2023
Q4 | $68K | Hold |
553
| – | – | ﹤0.01% | 949 |
|
|
2023
Q3 | $71K | Sell |
553
-12,500
| -96% | -$1.67M | ﹤0.01% | 949 |
|
|
2023
Q2 | $1.62M | Buy |
13,053
+101
| +0.8% | +$13.6K | 0.03% | 322 |
|
|
2023
Q1 | $1.9M | Sell |
12,952
-2,598
| -17% | -$384K | 0.04% | 345 |
|
|
2022
Q4 | $2.48M | Buy |
15,550
+4,970
| +47% | +$728K | 0.05% | 332 |
|
|
2022
Q3 | $1.41M | Sell |
10,580
-1,500
| -12% | -$228K | 0.04% | 321 |
|
|
2022
Q2 | $1.88M | Buy |
12,080
+582
| +5% | +$89.6K | 0.05% | 302 |
|
|
2022
Q1 | $1.79M | Sell |
11,498
-6,746
| -37% | -$979K | 0.04% | 356 |
|
|
2021
Q4 | $2.32M | Sell |
18,244
-3,104
| -15% | -$408K | 0.05% | 344 |
|
|
2021
Q3 | $2.78M | Sell |
21,348
-51,586
| -71% | -$7.79M | 0.06% | 304 |
|
|
2021
Q2 | $13M | Buy |
+72,934
| New | +$12.6M | 0.24% | 139 |
|
|
2018
Q3 | – | Sell |
-12,809
| Closed | -$2.21M | – | 722 |
|
|
2018
Q2 | $2.21M | Buy |
+12,809
| New | +$2.09M | 0.14% | 114 |
|
|
2017
Q1 | – | Sell |
-164
| Closed | -$17K | – | 706 |
|
|
2016
Q4 | $17K | Buy |
164
+34
| +26% | +$3.79K | ﹤0.01% | 702 |
|
|
2016
Q3 | $15K | Buy |
130
+52
| +67% | +$7.01K | ﹤0.01% | 718 |
|
|
2016
Q2 | $11K | Buy |
78
+29
| +59% | +$4.28K | ﹤0.01% | 584 |
|
|
2016
Q1 | $6 | Buy |
49
+15
| +44% | +$1.87K | ﹤0.01% | 679 |
|
|
2015
Q4 | $5K | Buy |
+34
| New | +$4.71K | ﹤0.01% | 814 |
|
Other funds holding JAZZ
EC
